Modernizing reporting and communication of isolated echogenic intracardiac foci and choroid plexus cysts in the cell‐free DNA era
Pregnancy · 2026-11 · 2 (6)
DOI: 10.1002/pmf2.70512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pregnancy, online erschienen am 19.11.2026. Verfasst von Yinka Oyelese und 3 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Echogenic intracardiac foci and choroid plexus cysts are among the most common findings on second‐trimester prenatal ultrasound. Historically classified as “soft markers,” they were incorporated into aneuploidy risk assessment in an era when screening relied on maternal age and serum analytes with limited performance. The widespread adoption of cell‐free DNA (cfDNA) screening has fundamentally altered this paradigm. With detection rates exceeding 99% for trisomy 21, the modest likelihood ratios associated with isolated EIF and CPC no longer meaningfully alter post‐test probability or clinical management. These findings are therefore best regarded as common normal variants rather than clinically significant markers of aneuploidy. Despite this transformation in prenatal screening, reporting and communication practices have changed little and remain highly variable, often influenced by historical practice patterns and medicolegal concerns rather than contemporary evidence. Numerous studies demonstrate that disclosure of isolated EIF and CPC may result in maternal anxiety, persistent concern despite reassurance, unnecessary diagnostic testing, and disruption of maternal‐fetal bonding. These effects may be amplified by immediate patient access to ultrasound reports and terminology that continues to imply pathology where none exists. This review examines the historical and contemporary evidence supporting a modernized approach to the reporting and communication of isolated EIF and CPC in the era of cfDNA screening and proposes an evidence‐based framework for clinical practice. In pregnancies with low‐risk cfDNA results and a normal detailed fetal anatomic survey, isolated EIF and CPCs should be regarded as benign findings without clinical significance. Contemporary evidence no longer supports the routine reporting and communication of these findings in the context of aneuploidy risk. When disclosure occurs, communication should be non‐alarmist, emphasize that these are normal variants, and avoid terminology suggesting increased risk for chromosomal abnormalities. Aligning reporting and communication with current evidence has the potential to reduce patient harm while promoting patient‐centered prenatal care.
Zitieren
APA
Oyelese, Y., Wang, M., O'Brien, B., & Bromley, B. (2026). Modernizing reporting and communication of isolated echogenic intracardiac foci and choroid plexus cysts in the cell‐free DNA era. Pregnancy, 2(6). https://doi.org/10.1002/pmf2.70512
Vancouver
Oyelese Y, Wang M, O'Brien B, Bromley B. Modernizing reporting and communication of isolated echogenic intracardiac foci and choroid plexus cysts in the cell‐free DNA era. Pregnancy. 2026;2(6). doi:10.1002/pmf2.70512
BibTeX
@article{Oyelese2026,
author = {Oyelese, Yinka and Wang, Michelle and O'Brien, Barbara and Bromley, Bryann},
title = {Modernizing reporting and communication of isolated echogenic intracardiac foci and choroid plexus cysts in the cell‐free DNA era},
journal = {Pregnancy},
year = {2026},
volume = {2},
number = {6},
doi = {10.1002/pmf2.70512}
}
EUVIMED